أعرض في EDS

5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)

التفاصيل البيبلوغرافية
العنوان:	5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
المؤلفون:	M. Callaghan, K.I. Ataga, L. De Franceschi, C. Minniti, N. Balachandran, D.-.C. Imbs, T. Perretti, J. Ramos, A. Sostelly, P. Bartolucci
المصدر:	HemaSphere. 7:26-26
بيانات النشر:	Ovid Technologies (Wolters Kluwer Health), 2023.
سنة النشر:	2023
مصطلحات موضوعية:	Hematology
تدمد:	2572-9241
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_________::f0193457c719458ec0bdb50edb78550d https://doi.org/10.1097/01.hs9.0000928320.14894.77
حقوق:	OPEN
رقم الأكسشن:	edsair.doi...........f0193457c719458ec0bdb50edb78550d
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	25729241